Stock Markets News

European shares fall as HSBC slump and energy fears offset AI glow

By Investing.com3 min readInvesting.com
European shares fall as HSBC slump and energy fears offset AI glowEuropean shares fall as HSBC slump and energy fears offset AI glow

European shares fall as HSBC slump and energy fears offset AI glow

 European shares slipped on Tuesday, failing to track an overnight rally across Wall Street and Asian bourses sparked by artificial intelligence exuberance, as a sharp post-earnings slide in banking giant HSBC and anxieties over persistent energy inflation weighed on regional risk appetite. 

The pan-European STOXX 600 index fell 0.43%, reversing a portion of Monday’s relief rally.

Germany’s DAX fell 0.2%, while France’s CAC 40 fell 0.4%. London’s FTSE 100 fell 1%, pressured by the banking sector. 

Global equity sentiment was buoyed overnight by a surge in technology equities following the blockbuster initial public offering of AI pioneer Anthropic.

However, European bourses were left largely stranded. Due to the continent’s distinct lack of large-cap technology concentration, European benchmarks have consistently sat out global tech expansions. The STOXX 600 has gained roughly 8% year-to-date, trailing behind the tech-heavy S&P 500, which has surged more than 12% over the same period.

Some pockets of European tech like BE Semiconductor saw its shares jump 9%, while Infineon gained 1%. 

Heavy corporate reporting slate

Instead of tech-driven momentum, continental trading desks are bracing for an avalanche of corporate updates as third-quarter reporting season kicks into high gear. About 30% of the STOXX 600 are scheduled to deliver earnings this week alone.

Financials acted as the heaviest drag on regional indices following quarterly numbers from HSBC.

Europe’s largest bank saw its shares tumble over 6%, despite reporting a jump in headline third-quarter pre-tax profit.  Underlying disclosures revealed a marked slowdown in its core wealth management division, alongside rising operating costs that overshadowed its headline earnings beat.

Conversely, defensive heavyweight Novartis AG provided a vital cushion. Shares of the Swiss pharmaceutical leader gained 2.1% after management raised its full-year guidance for core operating income. 

Central bank gauntlet looms with focus on energy-driven inflation

Beyond corporate updates, trading desks are defensively positioning ahead of a high-stakes gauntlet of major central bank rate decisions.

The Federal Reserve is widely anticipated to keep the target range for the federal funds rate unchanged at 3.75% to 4% at the conclusion of its two-day policy meeting on Wednesday, while the European Central Bank is similarly projected to hold its benchmark deposit facility rate steady at 2.50% on Thursday.

Despite the near-term pauses, European markets remain laser-focused on the policy messaging and economic commentary from ECB President Christine Lagarde.

With ECB policymakers increasingly vocal in warning that elevated natural gas and crude prices are reigniting second-round inflation risks across the single-currency bloc, fixed-income swaps continue to price an 80% likelihood of a follow-up 25-basis-point rate hike in December.